Tetratherix Limited (ASX:TTX)
3.880
-0.090 (-2.27%)
At close: Mar 6, 2026
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 196.97 million as of March 6, 2026.
Market Cap
196.97M
Enterprise Value
186.61M
Revenue
2.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.88
Market Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 196.97M, an increase of 29.58%. That is a compound annual growth rate of 46.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 196.97M | 19.31% |
| Dec 30, 2025 | 165.09M | 8.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 170.07M |
| Orthocell | 240.11M |
| Dimerix | 243.16M |
| Actinogen Medical | 150.18M |
| Recce Pharmaceuticals | 133.02M |
| Botanix Pharmaceuticals | 126.43M |
| Island Pharmaceuticals | 123.80M |
| Paradigm Biopharmaceuticals | 112.01M |